Specific mesoderm subset derived from human pluripotent stem cells ameliorates microvascular pathology in type 2 diabetic mice

Human induced pluripotent stem cells (hiPSCs) were differentiated into a specific mesoderm subset characterized by KDR(+)CD56(+)APLNR(+) (KNA(+)) expression. KNA(+) cells had high clonal proliferative potential and specification into endothelial colony-forming cell (ECFCs) phenotype. KNA(+) cells differentiated into perfused blood vessels when implanted subcutaneously into the flank of nonobese diabetic/severe combined immunodeficient mice and when injected into the vitreous of type 2 diabetic mice (db/db mice). Transcriptomic analysis showed that differentiation of hiPSCs derived from diabetics into KNA(+) cells was sufficient to change baseline differences in gene expression caused by the diabetic status and reprogram diabetic cells to a pattern similar to KNA(+) cells derived from nondiabetic hiPSCs. Proteomic array studies performed on retinas of db/db mice injected with either control or diabetic donor-derived KNA(+) cells showed correction of aberrant signaling in db/db retinas toward normal healthy retina. These data provide proof of principle that KNA(+) cells restore perfusion and correct vascular dysfunction in db/db mice.

Automated summary

Human induced pluripotent stem cells (hiPSCs) can differentiate into specific mesoderm cells and restore vascular dysfunction in diabetic mice.